>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

November 07, 2014

FDA MedWatch - Nellcor Puritan Bennett, 980 Ventilator System: Class I Recall - Software Issue May Stop Ventilator

Summary:

FDA MedWatch Nellcor Puritan Bennett 980 Ventilator System Class I Recall

October 25, 2014

FDA MedWatch - Intravia Containers by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Intravia Containers by Baxter Recall

October 20, 2014

Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter

Summary:

FDA Medwatch Alert 10-20-14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Addresses Key Findings and Recommendations of IOM Pain Report to Senate HELP Committee

Wednesday, February 29, 2012

ASA addressed the key findings and recommendations from the Institute of Medicine's (IOM) report, Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research, in an official Statement for the Record to the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP). The February 14 hearing entitled, Pain in America: Exploring Challenges to Relief, largely focused on the June 2011 IOM report. The IOM report assessed the current state of the science of pain research, care, and education and made numerous recommendations that the authors believe would advance the field of pain medicine. 

In the Statement for the Record, ASA highlighted key findings and recommendations of the IOM report that will help anesthesiologists provide more efficient and effective pain care for their patients. ASA agreed with the IOM report that pain is often a symptom of a disease, but chronic pain can be a disease in itself. Multimodal interventions should be used to care for patients with chronic pain, and when available, multidisciplinary programs should be used.  In addition, ASA was pleased that the IOM report calls for collecting timely and consistent data on pain and expanding pain research. 

ASA, in leading the implementation of the IOM report’s recommendations, is developing additional educational materials for patients that promote and enable self-management of chronic pain to enhance our existing patient-centered offerings.

While the IOM report highlights the need for better pain care, ASA expressed concern that “the IOM report calls into question state laws that restrict the scope of practice of nurses and recommends that educational programs for nursing 'have increased capacity to train providers who can offer advanced pain care' ” (quoting IOM report, pages 204, 210). To ensure patient safety and the highest quality of care, ASA reiterated its position that “interventional pain management is the practice of medicine provided only by qualified MDs/DOs.” 

In regard to public and physician education on chronic pain, ASA urged the Senate HELP Committee to reconsider mandating a public education campaign on pain management and expressed support for the NIH Pain Consortium’s new funding opportunity to create Centers of Excellence in Pain Education at medical, dental, pharmacy, and nursing professional schools. 

Click here to learn more about ASA’s advocacy in Pain Medicine.

Click here to read the official Statement for the Record.

« Back to Washington Alerts